Firefly BioWorks Abcam Gains Multiplexing, miRNA Assays via Firefly Buy; Sees Opportunities in Protein Analysis Premium Abcam was encouraged to buy Firefly BioWorks by its customers, who are more frequently complementing their protein analysis work with miRNA studies. Abcam to Acquire Firefly BioWorks for $28M The all-cash deal gives Abcam access to Firefly's multiplex assay biomarker-detection platform. Firefly Bio Raises $775K, Eyeing $1.5M NEW YORK (GenomeWeb) – Firefly BioWorks said in a document filed with the US Securities and Exchange Commission that it has raised $775,000 toward a targeted amount of $1.5 million. IP Watch: Illumina, Abbott, Roche, Rheonix, Firefly, Others Win US Patents Premium Lawrence Livermore National Security and The University of California have been awarded US Patent No. IP Roundup: Spanish Scientific Research Council, Callida, Firefly, Harvard, Nestec, and Others Premium The Spanish Scientific Research Council of Madrid, Spain, has received US Patent No. Oct 16, 2013 EMD Millipore to Distribute Firefly BioWorks' microRNA Profiling Assay Apr 18, 2013 Firefly Awards $120K in Research Products under Grant Program Premium Feb 14, 2013 Firefly Launches Grant Program for Company Products, Services Premium Feb 8, 2013 Downloads and Upgrades: PubmiR, Cytoscape 3.0, DNAnexus, and more. Premium Feb 7, 2013 New Products: Firefly's PubmiR Premium Aug 9, 2012 People in the News: NanoString's New VP of Global Sales; Miller Joins Firefly BioWorks Board Premium Jul 26, 2012 People in the News: Victor Ambros Premium May 23, 2012 Firefly Nets $500K Grant from Massachusetts Life Sciences Center Mar 22, 2012 With Funding In Hand, Startup Firefly BioWorks Introduces miRNA Detection Technology Premium Oct 21, 2011 MiRNA Firm Firefly BioWorks Raises $2M Aug 8, 2011 Firefly Nets $2M NCI SBIR Grant for MiRNA Assay Development Breaking News Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates Veracyte Q2 Revenues More Than Double on Test Volume Spike Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent Qiagen Q2 Revenues Grow 28 Percent CareDx Q2 Revenues Up 77 Percent Secondary Genetic Findings Often Requested if Given Second Chance, Study Finds The Scan Booster Push New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high. With Help from Mr. Fluffington, PurrhD Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic. Man Charged With Threatening to Harm Fauci, Collins The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials. Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.